Published in Stroke on September 04, 2008
Thrombus imaging in acute stroke: correlation of thrombus length on susceptibility-weighted imaging with endovascular reperfusion success. Eur Radiol (2014) 1.01
Asymmetry of deep medullary veins on susceptibility weighted MRI in patients with acute MCA stroke is associated with poor outcome. PLoS One (2015) 0.95
T2* "susceptibility vessel sign" demonstrates clot location and length in acute ischemic stroke. PLoS One (2013) 0.90
Thrombus branching and vessel curvature are important determinants of middle cerebral artery trunk recanalization with Merci thrombectomy devices. Stroke (2012) 0.86
Carotid I's, L's and T's: collaterals shape the outcome of intracranial carotid occlusion in acute ischemic stroke. J Neurointerv Surg (2014) 0.86
Intra-arterial therapy for acute ischemic stroke. Neurotherapeutics (2011) 0.81
Impact of CHADS(2) Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke. J Clin Neurol (2012) 0.81
Efficacy of Proximal Aspiration Thrombectomy for Using Balloon-Tipped Guide Catheter in Acute Intracranial Internal Carotid Artery Occlusion. J Korean Neurosurg Soc (2016) 0.77
Thrombus imaging in acute ischaemic stroke using thin-slice unenhanced CT: comparison of conventional sequential CT and helical CT. Eur Radiol (2012) 0.77
Association of Cortical Vein Filling with Clot Location and Clinical Outcomes in Acute Ischaemic Stroke Patients. Sci Rep (2016) 0.75
Thrombosis: Novel nanomedical concepts of diagnosis and treatment. World J Cardiol (2015) 0.75
Mechanically assisted intra-arterial thrombolysis in acute cerebral infarction. Exp Ther Med (2013) 0.75
Manual aspiration thrombectomy through balloon tipped guide catheter for rapid clot burden reduction in endovascular therapy for ICA L/T occlusion. Neuroradiology (2012) 0.75
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA (1999) 12.75
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol (2006) 10.51
The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke (2004) 4.67
The Interventional Management of Stroke (IMS) II Study. Stroke (2007) 3.83
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol (2006) 2.39
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 2.25
Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke (1996) 1.90
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation (1987) 1.89
Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke (2004) 1.59
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke (2007) 1.45
Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci (2004) 1.24
Factors influencing outcome and treatment effect in PROACT II. Stroke (2003) 1.10
Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke (2006) 1.04
Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke (2003) 0.96
Acute interventions for ischemic stroke: present status and future directions. J Endovasc Ther (2000) 0.80
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 6.79
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32
Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev (2009) 3.43
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke (2008) 2.58
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet (2009) 2.50
Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab (2007) 2.31
Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke (2010) 2.29
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology (2002) 2.18
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke (2005) 2.12
Diagnosis and initial management of cerebellar infarction. Lancet Neurol (2008) 2.08
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2002) 2.08
Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab (2008) 2.06
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol (2007) 2.05
Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke (2002) 1.97
Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res (2010) 1.89
Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest (2008) 1.81
Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab (2009) 1.80
Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med (2009) 1.73
Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke (2006) 1.70
Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging (2004) 1.69
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68
Changes in spleen size in patients with acute ischemic stroke: a pilot observational study. Int J Stroke (2012) 1.66
Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol (2011) 1.64
LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis (2008) 1.62
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62
Functional assessments in the rodent stroke model. Exp Transl Stroke Med (2010) 1.61
Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke (2007) 1.61
Inpatient rehabilitation centers and concern for increasing volume of ischemic stroke patients requiring rehabilitation. South Med J (2013) 1.60
Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke (2004) 1.59
Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol (2008) 1.59
Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation (2007) 1.58
Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol (2009) 1.52
Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke (2004) 1.50
Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med (2003) 1.48
What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke? J Stroke Cerebrovasc Dis (2012) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest. Resuscitation (2004) 1.46
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours. Stroke (2008) 1.43
Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke (2005) 1.42
A randomized, controlled trial to teach middle school children to recognize stroke and call 911: the kids identifying and defeating stroke project. Stroke (2007) 1.42
Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci (2009) 1.41
Thrombolysis in stroke despite contraindications or warnings? Stroke (2013) 1.40
Can comprehensive stroke centers erase the 'weekend effect'? Cerebrovasc Dis (2008) 1.39
Feasibility of carotid artery stenting in patients with angiographic string sign. Catheter Cardiovasc Interv (2010) 1.39
Prevalence of atherosclerotic plaque in young and middle-aged asymptomatic individuals: the Bogalusa heart study. South Med J (2011) 1.39
Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients. Int J Stroke (2014) 1.39
Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann Neurol (2002) 1.39
Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci (2009) 1.38